id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FMCSA-2011-0073-0008,FMCSA,FMCSA-2011-0073,Harmonizing Schedule I Drug Requirements; Correction,Rule,Final Rule,2012-02-22T05:00:00Z,2012,2,2012-02-22T05:00:00Z,,2012-02-22T14:40:07Z,2012-03978,0,0,0900006480fbd599
FMCSA-2011-0073-0007,FMCSA,FMCSA-2011-0073,Harmonizing Schedule I Drug Requirements,Rule,Final Rule,2012-01-30T05:00:00Z,2012,1,2012-01-30T05:00:00Z,,2012-01-31T19:56:46Z,2012-01905,0,0,0900006480fa8dea
FMCSA-2011-0073-0004,FMCSA,FMCSA-2011-0073,Harmonizing Schedule 1 Drug Requirements,Other,Acknowledgement Letter/Receipt,2011-08-01T04:00:00Z,2011,8,2011-08-01T04:00:00Z,,2024-11-07T22:32:59Z,,1,0,0900006480eca53d
FMCSA-2011-0073-0002,FMCSA,FMCSA-2011-0073,U.S. DOT/FMCSA - Categorical Exclusion Determinations,Other,Agency Response,2011-07-12T04:00:00Z,2011,7,2011-07-12T04:00:00Z,,2011-07-12T20:01:33Z,,0,0,0900006480ec0cfb
FMCSA-2011-0073-0001,FMCSA,FMCSA-2011-0073,Harmonizing Schedule I Drug Requirements,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2011-07-08T04:00:00Z,2011,7,2011-07-08T04:00:00Z,2011-09-07T03:59:59Z,2024-11-07T22:32:02Z,2011-17192,1,0,0900006480ebcd23